Citation: Ur. Nilsson et al., COMPLEMENT ACTIVATION LEADING TARGET-BOUND IGG WITH LOSS OF ITS NEUTROPHIL-ACTIVATING FUNCTION, The FASEB journal, 12(4), 1998, pp. 1698-1698
Citation: J. Svartengren et al., INTERACTION OF THE NOVEL ANTIPSYCHOTIC DRUG AMPEROZIDE AND ITS METABOLITE FG5620 WITH CENTRAL-NERVOUS-SYSTEM RECEPTORS AND MONOAMINE UPTAKESITES - RELATION TO BEHAVIORAL AND CLINICAL EFFECTS, Biological psychiatry, 42(4), 1997, pp. 247-259
Citation: Ta. Long et al., ALCOHOL INTAKE IN HIGH ALCOHOL-DRINKING (HAD) RATS IS SUPPRESSED BY FG5865, A NOVEL 5-HT1A AGONIST 5-HT2 ANTAGONIST, Pharmacology, biochemistry and behavior, 53(1), 1996, pp. 33-40
Authors:
BJORK A
EEGOLOFSSON O
SVENDSEN P
MOSTROM U
PELLETTIERI L
Citation: A. Bjork et al., ENDOVASCULAR TREATMENT OF A SPINAL ARTERIOVENOUS MALFORMATION IN A 21-MONTH-OLD BOY, Acta paediatrica, 83(12), 1994, pp. 1326-1331
Authors:
BJORK A
CHRISTENSSON E
ALBINSSON A
GUSTAFSSON B
PETTERSSON E
PETTERSSON G
SVARTENGREN J
ANDERSSON G
Citation: A. Bjork et al., IN THE SEARCH FOR A NOVEL CLASS OF ANTIPSYCHOTIC-DRUGS - PRECLINICAL PHARMACOLOGY OF FG5803, A 1-PIPERAZINECARBOXAMIDE DERIVATIVE, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1338-1347
Authors:
ALBINSSON A
BJORK A
SVARTENGREN J
KLINT T
ANDERSSON G
Citation: A. Albinsson et al., PRECLINICAL PHARMACOLOGY OF FG5893 - A POTENTIAL ANXIOLYTIC DRUG WITHHIGH-AFFINITY FOR BOTH 5-HT1A AND 5-HT2A RECEPTORS, European journal of pharmacology, 261(3), 1994, pp. 285-294
Authors:
MCMILLEN BA
JONES EA
HILL LJ
WILLIAMS HL
BJORK A
MYERS RD
Citation: Ba. Mcmillen et al., AMPEROZIDE, A 5-HT(2) ANTAGONIST, ATTENUATES CRAVING FOR COCAINE BY RATS, Pharmacology, biochemistry and behavior, 46(1), 1993, pp. 125-129
Citation: Rd. Myers et al., 5-HT(2) RECEPTOR BLOCKADE BY AMPEROZIDE SUPPRESSES ETHANOL DRINKING IN GENETICALLY PREFERRING RATS, Pharmacology, biochemistry and behavior, 45(3), 1993, pp. 741-747